Authors: Hartinger, J Folz, T Cussler, K

Citation: J. Hartinger et al., Clinical endpoints during rabies vaccine control tests., ALTEX-AL TI, 18(1), 2001, pp. 37-40

Authors: Leenaars, PPAM Hendriksen, CFM de Leeuw, WA Carat, F Delahaut, P Fischer, R Halder, M Hanly, WC Hartinger, J Hau, J Lindblad, EB Nicklas, W Outschoorn, IM Stewart-Tull, DES

Citation: Ppam. Leenaars et al., The production of polyclonal antibodies in laboratory animals - The reportand recommendations of ECVAM Workshop 35, ATLA-ALT L, 27(1), 1999, pp. 79-102

Authors: Fetterman, B Pawlick, G Koo, H Hartinger, J Gilbert, C Connell, S

Citation: B. Fetterman et al., Determining the utility and effectiveness of the NeoPath AutoPap 300 QC system used routinely, ACT CYTOL, 43(1), 1999, pp. 13-22

Authors: Zwerger, C Plesker, R Papadopulos, K Cussler, K Hartinger, J

Citation: C. Zwerger et al., A comparison of commercially available adjuvants in BALB/c-mice immunised with a weekly immunogenic peptide, ALTEX-AL TI, 15, 1998, pp. 83-86